
Cough is a prevalent symptom in patients with fibrotic interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF) and non-IPF fibrotic ILD. The study shows that cough severity worsens over time and is linked to poorer health-related quality of life, faster disease progression, and reduced survival. Cough severity was higher in IPF patients and increased irrespective of ILD-targeted therapy or lung function changes.
Like
Save
Share